vimarsana.com

Page 10 - ஒவ்வாமை ஆஸ்துமா வலைப்பின்னல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Report: Higher pollen concentrations correlated with increase in COVID-19 infections

Report: Higher pollen concentrations correlated with increase in COVID-19 infections By: Scripps National and last updated 2021-04-08 18:38:45-04 Spring is in the air and so is pollen. Research has shown the allergen can make respiratory illnesses worse and COVID-19 is no exception. Higher airborne pollen concentrations are correlated with increased COVID-19 infection rates, according to a recent report. “Pollen actually causes inflammation in your airways if you’re allergic, so you can get stuffy nose, coughing, wheezing, even asthma symptoms from it, similar to what you get with respiratory viruses and then the irony is if you suffer from allergies, you’re more likely to catch a respiratory virus or vice versa because your airways are already inflamed from one thing, such as pollen,” said Dr. Purvi Parikh, Allergist Immunologist at the Allergy & Asthma Network.

Report: Higher pollen concentrations correlated with increase in COVID-19 infections

Report: Higher pollen concentrations correlated with increase in COVID-19 infections
newschannel5.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newschannel5.com Daily Mail and Mail on Sunday newspapers.

Green Park Collaborative and Allergy & Asthma Network Publish a Core Outcome Set for Clinical Trials in Moderate to Severe Asthma

Green Park Collaborative and Allergy & Asthma Network Publish a Core Outcome Set for Clinical Trials in Moderate to Severe Asthma News provided by Share this article Share this article core across all phase 3 and 4 clinical drug trials for moderate to severe asthma. The report, published in the Annals of Allergy, Asthma and Immunology, describes the multi-stakeholder consensus process used to prioritize nearly 100 outcomes down to a final set of five core outcomes. Participants represented many perspectives, including patients, clinicians, researchers, payers, health technology assessors, regulators, and drug development companies. The coreASTHMA core outcome set is a triumph. Even in a condition like asthma, where the most important outcomes for clinical research might seem self-evident, valuable insights on outcome selection were gained through multistakeholder engagement. I am confident that as these insights are adopted into clinical research, producing more relevant data

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.